Practice Management News

Buprenorphine-naloxone combination and extended-release naltrexone were both safe and effective in managing patients with opioid use disorder, yielding nearly identical results, according to findings recently published in The Lancet.

AMA recently voted to advance the development of a comprehensive strategy that allows more consistent coverage of genomic and genetic tests and precision medicine, a move intended to enhance patient access to useful new genetic tests and therapeutics that have clinical impact.

The FDA issued a warning today about the potentially fatal risks linked to kratom, a plant-based product from Asia that the agency said is used to treat medical conditions such as pain, anxiety and depression, and used recreationally for its euphoric effects.

President Donald J. Trump has nominated Alex Azar II, the head of pharmaceutical company Eli Lilly’s U.S.-based operations until this past January, to be his next HHS secretary, as reported by The New York Times.

We are witnessing history. The explosion of new drugs into the hepatitis C marketplace has been both breathtaking and transformative. But, in HCV, we have peaked. Everything that happened in HCV, happened faster and more intensively than HIV but it follows the same storyline, with one exception: Drug pricing matters in HCV.

Survey results published in Mayo Clinic Proceedings reveal a significant level of discontent among physicians, with many considering scaling back or leaving practice altogether.

Annual health care spending increased from $1.2 trillion to $2.1 trillion between 1996 and 2013, fueled by a 50% rise in the price of health care services to $583 billion, according to findings recently published in JAMA.

ORLANDO — In this exclusive video from the World Congress of Gastroenterology at ACG 2017, outgoing ACG president Carol Burke, MD, vice chair of the department of gastroenterology and hepatology at the Cleveland Clinic Foundation, discussed a task force formed during her tenure that worked toward an alternative, less burdensome maintenance of certification (MOC) process.

ED patients with acute extremity pain had neither clinically important nor statistically significant differences in pain reduction at 2 hours when receiving a single dose of ibuprofen and acetaminophen or several different combinations of opioids and acetaminophen, according to findings recently published in JAMA.

ACP recently published a new position paper asserting that improvements to patient safety are gravely needed in the outpatient setting while offering recommendations to address the issue.